TrialLineage Concept
Angelman syndrome
Angelman syndrome is a rare neurodevelopmental genetic disorder caused by loss of functional UBE3A expression in neurons. It is characterized by severe intellectual disability, movement abnormalities, seizures, and minimal speech. Understanding its genetic mechanism has opened it to RNA-targeted therapeutic approaches.
In plain language
What is Angelman syndrome?
Angelman syndrome affects approximately 1 in 12,000 to 20,000 people. Children with Angelman syndrome typically show developmental delays by 6–12 months of age. The condition causes severe intellectual disability, little or no speech, motor difficulties including ataxia (unsteady gait), and frequent seizures. Many individuals also exhibit a characteristic happy demeanor with frequent smiling.
The condition is lifelong. Current management is supportive — antiepileptic drugs for seizures, physical therapy for motor function, and communication aids. There are no approved treatments that address the underlying molecular cause.
The genetic basis
Angelman syndrome is caused by loss of function of the UBE3A gene on chromosome 15q11.2-q13. In most neurons, only the maternal copy of UBE3A is active — the paternal copy is silenced through genomic imprinting. This means that if the maternal copy is deleted, mutated, or otherwise non-functional, neurons have no source of UBE3A protein.
The most common cause (~70%) is a de novo deletion of the maternal 15q11-q13 region. Other causes include UBE3A point mutations (~11%), paternal uniparental disomy (~7%), and imprinting center defects (~3%).
Why this disorder is therapeutically relevant
Unlike many genetic conditions where the causative gene is damaged or absent, most Angelman syndrome patients retain an intact paternal UBE3A gene — it is simply silenced in neurons. This creates a therapeutic opportunity: if the silencing mechanism can be disrupted, the paternal copy might be activated. This is the rationale for ASO-based therapies targeting the UBE3A antisense transcript.
Related concepts